---
title: "Telomir Pharmaceuticals (TELO.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/TELO.US/norm.md"
symbol: "TELO.US"
name: "Telomir Pharmaceuticals"
parent: "https://longbridge.com/zh-CN/quote/TELO.US.md"
datetime: "2026-05-21T21:45:52.083Z"
locales:
  - [en](https://longbridge.com/en/quote/TELO.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TELO.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TELO.US/norm.md)
---

# Telomir Pharmaceuticals (TELO.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.0300 | -0.0615 | -0.0340 | -0.1689 | -0.0732 |
| ROE | -72.89% | -127.90% | -118.20% | -12670.13% | -3618.50% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -990947.00 | -2.06M | -1.10M | -5.07M | -2.18M |
| 营业利润 | -1.04M | -2.13M | -1.15M | -5.07M | -2.19M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 5.79M | 7.34M | 7.40M | 829611.00 | 491188.00 |
| 权益乘数 | 1.17 | 1.24 | 1.06 | 1.72 | -3.05 |
| 每股净资产 | 0.1443 | 0.1720 | 0.2063 | 0.0158 | -0.0054 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 5.56M | 7.29M | 7.33M | 754323.00 | 402999.00 |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | - | - | - | - | - |
| 净债务 | -5.36M | -6.81M | -7.24M | -660891.00 | -309567.00 |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -1.77M | -1.20M | -927264.00 | -696445.00 | -863132.00 |
| 投资现金流 | - | - | - | - | - |
| 融资现金流 | 47351.00 | 1.16M | 7.50M | 1.05M | - |
| 自由现金流 | -1.15M | -699133.00 | -639660.00 | -3.46M | -50667.00 |
| 现金流充裕率 | -999.51% | - | - | - | - |
| 举债与偿债 | 224789.00 | 155518.00 | - | - | - |
| 资本支出 | - | - | - | - | - |